國藥科技股份(08156.HK)斥460萬人幣訂購10台口罩全自動化生產線
國藥科技股份(08156.HK)公布,已透過直接持股之全資子公司—深圳國科防偽科技有限公司與上工富怡智能製造(天津)有限公司訂立一份訂購合同。根據訂購合同,國科將以460萬元人民幣總價格向上工富怡訂購10台醫用一次性口罩全自動化生產線。
國科將其中6台設備以生產設備出資形式向合營 公司山東德吉醫療用品有限公司注資。在共同經營合營公司的前提下,充分利用高質量的核心生產設備創造營收。餘下4台設備計劃用於香港建立自己的生產線。公司正積極尋找可供使用之清潔車間,同時亦就此本地生產口罩項目向香港生產力促進局及香港科學園尋求彼等對建立基礎設施和清潔車間所提供的適切培訓、技術支援及其它相關之協助。
此次所採購的醫用一次性口罩全自動化生產線,屬全自動高端設備,生產量為每分鐘100片,國科將設備投放於合營公司廠房,協助其佈局高端生產線。新設備的投入使用,使合營公司能在短期內有效實現高生產效率,增加產能、降低成本、便於人手操作以降低損耗以及穩定生產。
在抗擊新冠狀肺炎疫情期間,公司已與珠海華發集團有限公司達成穩固的醫療物資採購供應合作關係,新設備的投入為合營公司以及集團提供穩定及高質的醫用口罩貨源打下堅實基礎。此外,隨著新設備在合營公司的順利啟動運作和正式投產,亦為公司未來在此領域向外擴張提供人員培訓、機器維護、成本控制等方面的經驗借鑒和寶貴參考。(jc/u)~
阿思達克財經新聞
網址: www.aastocks.com
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.